ClinicalTrials.gov
public full text
Public Domain
Efficacy and Safety of Cevira® in Patients With Cervical Histologic High-grade Squamous Intraepithelial Lesions (HSIL)
A double blind, prospective, randomized, placebo controlled, multi-center phase 3 study to evaluate efficacy and safety of Cevira® in patients with cervical histologic high-grade squamous intraepithelial lesions (HSIL).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Clinical Trial Evaluating Secondary HPV Vaccination After Treatment of High-grade Cervical Lesions#356516
- Strategies for Endocervical Canal Investigation in Women With Abnormal Screening Cytology and Negative Colposcopy#871409
- Evaluation of the Cobas® 4800 HPV Test for the Detection of High-grade Cervical Disease#836223
- Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3)#1183665
- Use of Human Papillomavirus Persistence for Determination of Treatment Efficacy Among Women With Cervical Dysplasia#800453
Record · ID 1338065
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive